Announcements Trials
Browse Landscape

Status

Unknown 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 72INDUSTRY 20NETWORK 3INDIV 3

Study Type

Observational 3Interventional 1

Sponsor

Conditions

Leukemia 81Breast Neoplasms 52Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Lymphoma 40Leukemia, Myeloid, Acute 33Neoplasms 29Colorectal Neoplasms 26Sarcoma 24Congenital Abnormalities 24Lung Neoplasms 20Carcinoma, Non-Small-Cell Lung 20Prostatic Neoplasms 19Neuroblastoma 19Ovarian Neoplasms 17Rectal Neoplasms 15Osteosarcoma 15Leukemia, Lymphocytic, Chronic, B-Cell 15Colonic Neoplasms 15Wilms Tumor 14Melanoma 14Multiple Myeloma 13Lymphoma, Follicular 13Leukemia, Myelomonocytic, Acute 13Leukemia, Megakaryoblastic, Acute 13Kidney Neoplasms 13Leukemia, Monocytic, Acute 12Leukemia, Erythroblastic, Acute 12HIV Infections 12Central Nervous System Neoplasms 12Lymphoma, Non-Hodgkin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Observational × Myasthenia Gravis × Clear all
NCT07217509 2025-10-16

PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry

CorEvitas

Enrolling by invitation
1,500 enrolled

Myasthenia Gravis

NCT06259071 2024-02-14

MuSK 1000

Myasthenia Gravis Rare Disease Network

Unknown
1,000 enrolled

Myasthenia Gravis

NCT04667650 2020-12-16

MYASTEN

Fondation Ophtalmologique Adolphe de Rothschild

Completed
151 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡